Product Information
CEFADROXIL 500 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2690 per EA under NDC 57237009601. Its NADAC has been published 608 times since Feb 11, 2015.
FDA first approved this application on Jan 25, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237009601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFADROXILApproval Type
Generic (ANDA)
FDA Application
ANDA065352FDA Approved
1/25/2007
TE Code
AB
On Market Since
1/25/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFADROXIL 500 MG CAPSULE has been published 608 times since Feb 11, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2690 per EA |
|---|---|
| All-time high | $0.3139 (Oct 11, 2023) |
| All-time low | $0.1740 (Nov 21, 2018) |
| 52-week high | $0.3014 |
| 52-week low | $0.2690 |
| Median price | $0.2419 |
| Average price | $0.2448 |
| Largest weekly change | -29.4% (Nov 21, 2018) |
| Weeks tracked | 608 |
| Tracking since | Feb 11, 2015 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefadroxil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFADROXIL 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFADROXIL 500 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.2690 per EA (NDC 57237009601), effective Sep 30, 2026.
How has the price of CEFADROXIL 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFADROXIL 500 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 608 weekly CMS publications since Feb 11, 2015.
What are the highest and lowest recorded NADAC prices for CEFADROXIL 500 MG CAPSULE?
Since Feb 11, 2015, the NADAC for CEFADROXIL 500 MG CAPSULE has ranged from a low of $0.1740 (Nov 21, 2018) to a high of $0.3139 (Oct 11, 2023), with a median of $0.2419 per EA.
Are there cheaper alternatives to CEFADROXIL 500 MG CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFADROXIL 500 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFADROXIL 500 MG CAPSULE?
CEFADROXIL 500 MG CAPSULE (NDC 57237009601) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.